Pfizer PGN 165 (Lyrica CR 165 mg)
Generic Name: pregabalin
Pill with imprint Pfizer PGN 165 is Beige, Elliptical / Oval and has been identified as Lyrica CR 165 mg. It is supplied by Pfizer Inc..
Lyrica CR is used in the treatment of neuropathic pain; diabetic peripheral neuropathy; postherpetic neuralgia and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica CR 165 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for Pfizer PGN 165
Lyrica CR
- Generic Name
- pregabalin
- Imprint
- Pfizer PGN 165
- Strength
- 165 mg
- Color
- Beige
- Size
- 18.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Gamma-aminobutyric acid analogs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00071-1027
More about Lyrica CR (pregabalin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: gamma-aminobutyric acid analogs
- FDA Alerts (2)
Consumer resources
Other brands: Lyrica
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
